These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 25136022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW, Walker JR, Alland D, Barry CE, Boshoff HI.
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
    [Abstract] [Full Text] [Related]

  • 3. MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target.
    Poce G, Consalvi S, Biava M.
    Mini Rev Med Chem; 2016 Apr; 16(16):1274-1283. PubMed ID: 26776226
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
    La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava M, Raju RM, Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR, Sacchettini JC, Manetti F, Botta M, De Logu A, Rubin EJ, De Rossi E.
    Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
    Grzegorzewicz AE, Pham H, Gundi VA, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SE, Korduláková J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M.
    Nat Chem Biol; 2012 Feb 19; 8(4):334-41. PubMed ID: 22344175
    [Abstract] [Full Text] [Related]

  • 8. MmpL3 inhibitors as antituberculosis drugs.
    Shao M, McNeil M, Cook GM, Lu X.
    Eur J Med Chem; 2020 Aug 15; 200():112390. PubMed ID: 32447196
    [Abstract] [Full Text] [Related]

  • 9. Specifically Targeting Mtb Cell-Wall and TMM Transporter: The Development of MmpL3 Inhibitors.
    Luo Q, Duan H, Yan H, Liu X, Peng L, Hu Y, Liu W, Liang L, Shi H, Zhao G, Hu J.
    Curr Protein Pept Sci; 2021 Oct 26; 22(4):290-303. PubMed ID: 33882806
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB, O'Malley T, Dennison D, Shelton CD, Sunde B, Parish T.
    mSphere; 2020 Oct 14; 5(5):. PubMed ID: 33055263
    [Abstract] [Full Text] [Related]

  • 13. Deciphering the possible role of MmpL7 efflux pump in SQ109 resistance in Mycobacterium tuberculosis.
    Jing W, Zhang F, Shang Y, Shi W, Yao C, Zhang X, Chu N, Lu J, Yuan J.
    Ann Clin Microbiol Antimicrob; 2024 Sep 28; 23(1):87. PubMed ID: 39342331
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.
    Li W, Sanchez-Hidalgo A, Jones V, de Moura VC, North EJ, Jackson M.
    Antimicrob Agents Chemother; 2017 Apr 28; 61(4):. PubMed ID: 28115355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.